May 2009

Guest Commentary: Quality in Clinical Research — An Indian Perspective

Thursday, May 28, 2009

At a recent ACRP chapter meeting in India, industry leaders participated in a panel discussion on quality in clinical research in India. The panelists included: Larisa Nagra Singh, senior director, Asia Pacific ,ICON; Dr. Sacchidananda, dermatologist, registrar evaluation, Rajiv Gandhi University of Health Sciences, Bangalore; Suresh Ramu, vice president, Quintiles; Mitesh Patel, head, CTL Services,  Quintiles India and director, clinical operations, Bangalore; and Dr. Anil Shinde, clinical operations,  director, NovoNordisk. The discussion was moderated by Dr. Raman Shetty, director clinical research, Allergan, India. The following is an excerpt from that discussion prepared by Dr. Shetty of Allergan and Pratibha Nadig, M.D.; Medha Joshi, M.D.; and Santosh Hegde (all of the Bilcare Research Academy, Bangalore, India)
.

[Read More]

Encorium Cuts Loss by $1.8M

Friday, May 22, 2009

Following Encorium Group’s announcement of plans to sell its assets, the Wayne, Pa.-based contract research organization (CRO) released its first quarter financial results earlier this week, reporting a significant decrease in net loss for Q1 2009 compared with the same period last year.

[Read More]

Encorium Plans Sale to Pierrel SpA

Tuesday, May 19, 2009

Just a week after announcing plans to sell the assets of its U.S. business to a global based contract research organization (CRO), Wayne, Pa.-based Encorium Group has scrapped those original plans and signed a letter of intent with another international CRO.

[Read More]

etrials Cuts Costs—and Losses in Q1

Wednesday, May 13, 2009

eClinical vendor etrials Worldwide cut its net loss for the first quarter 2009 in half from the same period 2008 by reducing operating expenses, the company said. Net loss for Q1 was $960,000, compared with $2 million in Q1 2008—and $5.5 million in the fourth quarter 2008.

[Read More]

Encorium Announces Plans to Sell

Tuesday, May 12, 2009

Wayne, Pa.-based contract research organization (CRO) Encorium Group said yesterday that it has entered into two non-binding letters of intent to sell the assets of its U.S. business, Encorium Group, and its wholly owned European subsidiary, Encorium Oy.

[Read More]